US$ 23.61
dihexa clinical trials status 2025 or 2026 dihexa clinical trial human DIHEXA CAPSULES Diabetes Clinical Trials: Emerging Trends
Description
Adjusting the dosage of the medication is recommended for therapies lasting longer than 4 weeks

70754-23-3 Source Synthetic Form Powder Description Phospho DSIP is also named: Delta (Phospho) Sleep Inducing Peptide, pDSIP

Effective therapy is justified in preventing serious conditions that may develop due to improper treatment or neglect of symptoms

The CAS number for AOD9604 is 386264-39-7, which uniquely identifies the compound for research and regulatory documentation
